chair powel speak riksbank
 mich sentiment may cs estimate
evan bostic speak dalla fed
panel technology-rel disrupt
uupgrad outperform neutral separ rhetor realiti expect elect nois rais estim
six-oh -six revis estim rais target price
worth wait deal boost growth rais estim target price
oper issu gap put pressur deliv neutral lower estim target price
weather surpris compstore under-perform stori intact outperform lower estim
pegvalias approv fda expect rais estim target price
ep reaffirm pre-announce lower estim
torrid pace continu lift estim target price
muscl milk lose armor stay consensu revis estim
alcoa under-valued aluminum tight underappreci reiter outperform lower estim
compel micro macro level rais estim target price maintain outperform
labcorp america lh outperform
takeaway analyst day
updat offer steel partner
first data sell central european op sia
road manag
si bp provid may evhc signific decreas
si bp among mco may si fall convert retir
 pick across region new washington state medicaid award
short interest declin hct highlight
cs steel import monitor april prelim censu may partial licens data
vehicl migrat provid scale advantag larger firm
analyst disclosur credit suiss seek busi compani cover research
report result investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest
cs alpha miner focu articl alcoa under-valued aluminum tight underappreci
receiv product pleas specifi credit suiss contact email call
uupgrad outperform neutral separ rhetor realiti expect elect nois rais estim
higher voltag june mark end ontario provinci elect campaign voter head poll
unfortun ontario power polit electr commonli refer hydro much canada long
often neg histori backdrop hydro one becom part campaign rhetor neg
impact share price vantag point rhetor contrast underli realiti clearli
polit risk associ ontario elect yet declin share last month look
overdon declin support better risk-reward relationship upgrad hydro one outperform neutral
call catalyst ontario power polit date back year realli see situat
would differ time except protect govern agreement provinc upcom
elect pre post like provid tactic trade opportun yet close path on-going
busi transform near-term focu
invest thesi hydro one attract asset base reason amount embed growth potenti upsid
incent regul
valuat revis outperform rate target obtain sever approach includ impli
price-to-earnings multipl ep ev/ebitda multipl target dividend yield impli
bp spread normal cdn bond yield result adjust model increas ep
risk rate target includ polit realiti percept lower growth ontario
regulatori chang increas interest rate
six-oh -six revis estim rais target price
reiter outperform rate rais tp follow strong result limit
disclosur blur bill encourag reacceler cloud revenu growth larg deal momentum upward
revis revenu guidanc reiter target rise subscript mix also distort bill
manag emphas softwar revenu licens cloud growth rpo bill
increasingli strateg result strengthen view secur increasingli data analyt orchestr problem
requir shift next-gen analytics-bas strategi secur remain mix believ
sit center sever secular trend iot support long term growth
solid licens cloud guidanc revis upward licens y/i vs street y/i led
top-lin beat despit sub-season splunk cloud exhibit strength reacceler y/i
cloud rev bill guidanc reiter overal revenue guidanc rais
vs prior non-gaap oper margin guidanc retain rpo remain
perform oblig metric introduc vs
expand custom partner base net custom add lacklust encourag manag
reiter custom revenu goal solid deal y/i also suggest rise
strateg import enterpris custom
model chang adjust non-gaap ep
target price reiter outperform target price base dcf analysi risk tp includ
heighten competit failur add new custom
receiv product pleas specifi credit suiss contact email call
worth wait deal boost growth rais estim target price
announc in-network contract market close announc reach
agreement unit healthcar nation largest health plan carrier would make lab servic in-network
provid manag care offer effect jan slightli ten year ago sign
exclus nation contract lead competitor labcorp lh also announc today extens
contract believ quest new in-network contract pave way share gain particularli small
region lab oper taken advantag out-of-network-statu recent year
reaffirm lt target point high end rang quest reiter lt revenue growth target mid
high singl digit earn growth target compani said expand relationship move
higher end state rang rais estim respect
previous new estim repres growth compani said
previous expect exceed ep even contract announc today
new contract separ distinct strong busi momentum alreadi place optum recent year
captur signific share lab busi gener optumcar physician network
importantli say term price optum-rel busi impact new contract
up-front cost new contract fund tax reform invest way background said
plan invest mln mln tax reform save mln go employe remaind
go fund growth initi
valuat rais ep estimate prev tp prev base
ep estimate risk includ need continu organic/acquisit growth oppti reimburs chang
oper issu gap put pressur deliv neutral lower estim target price
lean portfolio off-set troubl core-gap noisi account chang calendar shift ep
miss cse/street lower compstore vs cse/street ex-credit merch margin
vs cse suffer on-going operations/inventori issu continu pressur ep
improv qtd trend weather turn favor on-going aggress cost control could help stabil
ep core-gap pressur extend beyond think reiter guid lower
vs reli much stabl trend low visibl retail backdrop see risk neg ep
on-going gap miscu pressur ep ep miss cse/street larg due lower compstore
vs cse/street yoy ex-credit vs cse flat merch margin yoy due unfavor
weather drag elev inventori clearanc core-gap partli off-set occup leverag due
week time shift sg leverag larg due time shift
lower ep miss lower ep base compstore guid flat
slightli op margin yoy tax rate ep base compstore op
valuat lower tp base ebitda risk chang macro/consum trend
receiv product pleas specifi credit suiss contact email call
weather surpris compstore under-perform stori intact outperform lower estim
weather impact surpris compstore under-perform vs marmaxx comp despit
less exposur clearli weather-impact market even give credit weather drag
adjust comp trend chang comp marmaxx prior qtr expect
modest nt stock headwind given recent valuat premium vs see
fundament chang stori still see opportun expand proven format untap us
market higher-confid ep driver vs driver like home/ecom like margin-dilut scale
after-hour trade mid-point ebitda guidanc in-lin see
pullback buy opportun maintain outperform
help calendar/expens shift report ep vs cse/street compstore vs
cse total rev vs cse/street sale benefit calendar shift
vs cse flat help lower distribut cost packaway expens time shift
benefit ep sg de-lever vs cse
maintain ep maintain ep base rev flat sg yoy
ep assum ebit yoy vs due shift packaway expens
year stepped-up wage invest start
valuat target price base ebitda line current trade multipl
impli ep risk includ deceler macro trend increas competit
pegvalias approv fda expect rais estim target price
biomarin guarante seventh commerci product line expect announc fda approv
palynziq pegvalias afternoon product box warn anaphylaxi risk rem program
gener expect given clinic trial experi see pegvalias pdufa deep-div detail expect
either major hurdl commerci uptak pegvalias give manag second fda win two year follow
brineura approv
clear commerci launch strategi commerci launch priorit pegvaliase-experienc clinic follow
larg pku clinic involv clinic trial expect transit vast major
clinic trial patient commerci year-end compani establish flat gross price guid
averag annual net price per patient slightli expect highlight path upsid
pegvalias valrox note believ consensu medium-term pegvalias revenu conserv could beat
investor expect remain confid pegvalias market opportun support strong phe
lower adequ rem program oner strong clinician interest/int treat
valuat reiter outperform rais tp increas program po
adjust price assumpt line manag guidanc ad valuat risk
thesi includ clinic regulatori commerci headwind rais ep estim
receiv product pleas specifi credit suiss contact email call
two-step br stock rough day much day lower ebitda guidanc
consensu cse midpoint stock hors past month
today outperform oih driller group question
guidanc light rel consensu could least part manag conserv br post adjust
ebitda origin guidanc given midpoint
liquid issu handl heel two success bond offer total along oem
recoveri focu turn off-shore recoveri look set glacial tick short-term nsea/gom work
help particularli deepwat expect recov meaning way maintain
tp ebitda
outlook br look set gener posit year cs reduct capital-expenditure defer
reduc non-aircraft capital-expenditure revenu guidanc light
consensu midpoint like due return leas aircraft contract roll off africa despit lower revenu
ebitda guidanc y-i come combin reduct rent expens
reduct sg ep move reflect updat guidanc activ assumpt risk
includ fleet oil price equip oversuppli capital-expenditure
earn br report adjust ep beat street driven revenu vs consensu
cs includ reimburs adjust ebitda consensu ebitda margin
q-q weaker margin apac/america partial off-set increas europe/caspian nsea
margin q-q continu robust lower ep estim
ep reaffirm pre-announce lower estim
ep short consensu adj ep miss estim higher
revenu off-set lower profit higher interest expens lower chang healthcar equiti incom
partial off-set lower tax incom remind pre-announce ep
guidanc april re-affirmed thu monument model chang maintain
ep tp lower ep estim
revenu ahead profit light revenu growth top better pharmaceut distribut
vs estimate vs estimate includ acquisit contribut medsurg vs
estimate also strong gross margin degrad bp bp plan higher administr
expens contribut ebitda margin deterior bp bp estim focu distribut
solut adj oper profit margin improv y/i bp expect gener
billion cash help fund acquisit million share repurchas
reiter under-perform report larg non-ev follow recent pre-announce target
re-affirmed includ acquisit msd also provid increment guidanc detail new segment call
less inspir oper profit growth flat -msd core us pharma specialti unit despit contribut
recent acquisit reflect custom consolidation/loss said remain optimist
prospect claruson call commentari indic potenti broader relationship beyond gener sourc
appeal well note stabl drug price environ broader posit read-through suppli chain
receiv product pleas specifi credit suiss contact email call
torrid pace continu lift estim target price
bottom line biennial investor day boost lt revenu growth target prior
emphas multi-facet growth strategi entail tangibl product enhanc geograph expans
penetr orthodont dental commun grow digit adopt broader foray teen market
walk away increment encourag competit posit despit evolv landscap lt growth
prospect rais ep stronger top-line profit trajectori tp move
higher view
divers global growth driver continu activ expand market reach via on-going innov
comprehens offer applic address market year vs current
expand case whop increment patient could benefit ortho solut global
addit driver expand digit ortho adopt retail store financ intern opportun emphasi
china also facilit sustain top-line momentum head start competit yet appear
substant fashion continu innov prove far behind competitor offer
comprehens compar solut other employ decade-old technolog
buy momentum thesi remain improv clinic awar consum sentiment technolog
enhanc expand geograph teen market focu drive sustain double-digit growth
improv profit thereon albeit time scalabl cost base ev/ebitda trade premium
dental implant manufactur straumann view warrant light abil exceed high
expect continu innov effect market strategi risk competit econom malais
muscl milk lose armor stay consensu revis estim
hormel ep miss consensu beat estim manag describ result
line expect reiter guidanc year howev oper profit miss consensu
estim muscl milk busi suffer anoth setback due poor execut intens
competit conveni channel commod side turkey busi remain pressur due
weak whole bird price addit manag team remain hazi quantifi save signific suppli
chain consolid effort underway past four month get sens reinvest
autom higher freight labor cost larg off-set effici gain result remain
consensu fy estim versu consensu guidanc expect
ep growth fy
valuat target price neutral rate reflect valuat multipl ebitda premium brand
food peer compar discount histor believ hormel value-ad product portfolio exposur on-
trend protein food pristin balanc sheet merit premium multipl
alcoa under-valued aluminum tight underappreci reiter outperform lower estim
updat estim conjunct new weekli product cs alpha miner focu articl
under-valued aluminum tight underappreci week focu articl discuss take aluminum
market remain bullish medium term outlook see under-valued signific capit return
potenti maintain price target modestli bring ebitda
earli mark market alumina price normal faster anticip also updat model
account recent debt offer pension fund risk big movement commod price includ
aluminum alumina
receiv product pleas specifi credit suiss contact email call
labcorp america lh
compel micro macro level rais estim target price maintain outperform
rais tp maintain outperform rate increas target price credicorp
mainli result stronger fx forecast support resili recent usd
strength roll-ov partial off-set increas cost equiti assumpt back
increas us risk-fre rate spite solid perform stock year ago year-to-d
outperform peer latam reiter outperform rate bap given compel risk-reward profil
owe still attract upsid potenti new target support posit macro backdrop peru well
solid earn outlook cheapest stock latam place credicorp top pick region
given reduc polit nois increas govern peru sinc presid vizcarra took offic contrast
higher uncertainti aris polit landscap brazil mexico consid resili peruvian
currenc vi -- vi latam market
compel earn compound-annual-growth-rate increas recur net incom forecast s/
decreas forecast s/ back lower nii estim mainli
explain lower secur volum off-set lower cost risk spite fine-tun
forecast continu anticip compel earn outlook credicorp growth recur profit
earn compound-annual-growth-rate period well growth loan portfolio nim behav rel
stabl go forward expect nice perform risk-adjust margin boost addit cost risk
improv suggest result contain opex growth key lever earn growth
expect grow compound-annual-growth-rate vi -- vi y/i effici gain abl partial off-set
expens relat compani on-going digit transform new forecast place us consensu
contract move non-exclus close lh disclos renew current exclus contract
slate expir howev continu particip nation provid
laboratori servic patient non-exclus basi dynam view broadli anticip
unsurprisingli quest diagnost simultan announc new relationship also non-exclus
contract remind revenu current repres estim lh lcd revenu
total compani sale today announc come year investor concern implic intern
competit loss exclus serv overhang lh share addit pama lh
provid detail financi impact loss exclus assess multipl scenario maintain
current assumpt earli junctur analysi purpos lh lost half associ revenu overnight
rather aggress assumpt would repres ep headwind sever variabl
consid importantli potenti offset
reiter outperform remain unclear implic lh loss exclus exclus contract
aetna aet would expect outcom lh/unh potenti call question dgx/aet contract see
aj rice investor meet note event aet contract also open lh could spur increment
share gain lh smaller region lab previous benefit exclus natur
contract continu view multipl avenu growth lh despit today news includ role lead
consolid smaller lab oper post-pama world aforement organ market share gain region
lab notabl strengthen perform covanc view impli valuat disconnect
reiter outperform
receiv product pleas specifi credit suiss contact email call
takeaway analyst day
week attend analyst day eindhoven netherland takeaway provid
eu outlook remain solid color capac management upbeat european market indic order intak
continu strong target expand share market medium term current
look vocat market particular provid greater aftermarket opportun eindhoven facil
current run near capac leyland facil run singl shift north america facil
run near capac upsid avail swing facil allow variabl
product beyond
part strategi remain critic part continu meaning contributor earn segment profit
doubl sinc back prolifer engin servic part well sale growth
new products/in trp trp retail store current trp locat countri
locat custom trp store new dealer network same-stor retail sale
mx engin current achiev penetr near- mid-term
target penetr product greater mid- long-term
thought emerg technolog strategi appear clear predict mainten advanc
fleet manag lesser extent autonomi expect beyond advanc driver assist
also appear import initi auto emerg brake traffic stop go lane keep
platoon object detect driver monitor still outlook ev remain somewhat
unclear management note econom feasibl ev still signific uncertainti though make
invest prepar futur
updat offer steel partner
steel partner propos acquir bw per share may steel partner current own
share outstand bw submit propos board bw acquir share current own
cash propos came form non-bind indic interest price reflect premium
bw stock price follow today close
offer includ asset megtec indic interest base upon acquisit entir
bw includ busi megtec recal bw explor strateg altern
busi help strengthen balanc sheet bw paid roughli acquir busi estim
carri high singl digit margin impli valuat time ebitda megtec top line probabl
lower rel bw acquir busi end market recent start rebound bw
manag indic result sale megtec expect conclud
take believ board decis function level interest compani
receiv megtec multipl busi get discuss well
progress/execut renew project
first data sell central european op sia
process busi sold first data announc afternoon sell card process busi
central eastern european countri european payment compani transact provid
payment card transact employe manag po termin atm countri
busi sold transact expect close
impact revenu revenu gener busi sold part fdc
global busi solut segment overal revenu gener global busi solut
revenu gener emea region
neutral news neutral announc divest busi cloud growth visibl extent
rel small divestitur posit potenti free cash reduc debt
receiv product pleas specifi credit suiss contact email call
overal posit futur come away posit stock follow analyst day remain bullish
stori found tone posit sever new initi product announc includ deeper
relationship googl new cash card progress venmo monet mani way work
expand integr platform improv valu proposit merchant consum
lack tpv guid rais question view outlook line prior guidanc exclud acquisit
share repurchas believ market may react neg manag decis withdraw tpv guidanc
expect decis could relat transit may caus tpv choppi medium
term busi roll
maintain outperform maintain current estim current ep compound-annual-growth-rate line revis
guidanc note upsid could come better margin expans higher share repurchas izettl
acquisit drive addit ep headwind
road manag
manag meet takeaway host investor meet ceo mari ann heino cfo crowley
ir director meara murphi manag re-affirmed previou guidanc call top-line improv
midpoint ebitda rang vs incl ge benefit reflect continu intern
invest emphas competit advantag defin revenu support continu solid
growth core product line make chang estim walk away meet
increment construct pipelin growth prospect view recent stock move sinc
begin may vs somewhat overblown downplay recent competit concern
highlight ampl driver flagship defin remain industri leader market share amidst healthi industri
growth compound-annual-growth-rate expir defin composit matter patent repres
overhang awar upcom gener competitor wing nt importantli activ pursu new
indic formul offer increment driver time regard technelit revenu top-
sell nuclear product manag deemphas commentari launch
potenti compet product due lt natur radiopharmaci contract year claim
certain pronounc effici advantag potenti aggress view
next capit deploy focus opportun in-licens deal possibl well
remain focus leverag microbubbl franchis includ higher margin defin product
altern diagnost opportun therapeut adjac focu outpati depart medic
offic order pave new path growth diversifi portfolio
si bp provid may evhc signific decreas
si bp may provid includ hospit first half may short interest si
percentag float across healthcar provid within coverag plu qhc cover bp averag
si increas qhc bp bp bp
second period row evhc greatest declin short interest bp
evhc bp si fell significantli well bp howev evhc still
among highest short interest group compani highest si percentag float
evhc
hospit si decreas bp may first half may si percentag float decreas bp among
six public hospit compani averag y/i basi hospit si increas bp averag hospit
increas si y/i includ bp qhc bp lpnt bp bp si decreas
bp bp
si provid bp y/i y/i basi si provid includ hospit decreas bp
averag compani experienc y/i increas provid hospit includ evhc bp
bp bp compani see decreas includ bp bp md
bp bp bp bp
day cover day provid day hospit day cover among healthcar provid
decreas day averag first two week may day cover among hospit compani decreas
day time period provid highest day cover day day
receiv product pleas specifi credit suiss contact email call
si bp among mco may si fall convert retir
si bp may first half may short interest si percentag float across
increas bp averag si increas bp aet bp ci bp si
decreas bp bp believ drop short interest like due unwind
hedg convert bln note may roughli mln share si flat wcg
continu highest si percentag float among manag care compani follow
wcg ci si driven part hedg relat compani in-the-money convert
bond major mco aet ci si decreas bp may
major si bp y/i si bp y/i across broad group y/i basi major si
bp averag individu compani increas ci bp off-set y/i decreas
bp aet bp bp unchang y/i two acquir ci
would natur short arb play pend transact si bp bp respect
y/i overal group decreas si bp y/i si increas bp y/i wcg si
decreas bp bp respect
day cover day major day broad group day cover among broad
group day averag decreas off-set increas aet ci
wcg highest day cover day follow wcg day
 pick across region new washington state medicaid award
mix may washington state author announc appar success
bidder eight addit region servic area state addit state select amerigroup
third imc program southwest washington region today announc molina
healthcar would mco select imp program across ten region pick six region
coordin pick five region commun health wa not-for-profit
select five region imc program select mco provid full continuum behavior
physic health servic imc program current live two region expect go live five region
final three region state accept bid mco current medicaid manag
contract state
potenti opportun base latest enrol data current enrol mln live
state follow commun health given modest
market share state current select everi region would suggest opportun potenti enrol
gain assess enrol would shift incumb mco hard state shift
region contract award new program versu previous counti base award howev inclus
behavior health servic new program repres increment revenu opportun
mco state
short interest declin hct highlight
short interest decreas hct univers short interest univers healthcar technolog distribut
stock declin averag first half may led anim health hcit drug distributor
cros/clin laboratori short interest increas dental pbms/pharmaci
compar decreas health sector
largest decreases/increas across hct univers short interest decreas dramat medpac
premier lantheu largest
increas sector express script
syneo health
highlight outperform zoeti outperform short interest declin
recent period trend view continu continu believ transit year
task hand daunt term growth aspir cost structur complex view
substanti opportun improv new regim term sale execut cost save note
encourag recent insid buy recent ir shift disappoint short interest zoeti increas
recent period trend view revers follow healthi experi strong cash flow
characterist support capit deploy aspir evidenc abaxi deal host
meet manag next week may offer potenti relev anim health insight
receiv product pleas specifi credit suiss contact email call
cs steel import monitor april prelim censu may partial licens data
total april import increas march
total flat roll import april increas march
rebar import increas march
impli total may import m/m
vehicl migrat provid scale advantag larger firm
believ increasingli critic asset manag provid client wide offer invest product across
multipl vehicl option number price point match client demand addit retail broker need provid
conflict-fre advic transpar low cost option client run risk lose market-shar industri
leader schwab fidel oper low cost platform complement advic regul us
europ acceler trend even though dol rule like dead
us retail broker industri aua continu shift toward advisori fee-bas brokerag commission-bas
ria model win client want advisor act fiduciari model avoid conflict interest
specif simplifi transpar advisori model easi consum understand wrap fee advisor
manag fee asset manag ria client win togeth asset grow model broker
firm compens via distribut shelf-fe asset manag cut complic method
includ up-front commiss trailer like fee sec look close share class
sold channel share class select disclosur initi june deadlin firm adjust
